Comparison of alanine aminotransferase, white blood cell count, and uric acid in their association with metabolic syndrome: A study of Korean adults

Endocrine Journal

Volumn 55, Issue 6, 2008, Pages 1093-1102

  Kang, Yang Ho ^a,b   Min, Hong Gi ^b,c   Kim, In Ju ^a   Kim, Yong Ki ^a   Son, Seok Man ^a,b  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University Hospital   (South Korea)

^c Pusan National University Yangsan Hospital   (South Korea)

Author keywords

Alanine aminotransferase; Metabolic syndrome; Uric acid; White blood cell count

Indexed keywords

ALANINE AMINOTRANSFERASE; URIC ACID;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE MARKER; FATTY LIVER; FEMALE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; PREVALENCE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SMOKING HABIT; URIC ACID BLOOD LEVEL;

ADULT; AGED; ALANINE TRANSAMINASE; BLOOD GLUCOSE; BLOOD PRESSURE; FEMALE; HUMANS; INSULIN RESISTANCE; KOREA; LEUKOCYTE COUNT; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE; URIC ACID; YOUNG ADULT;

EID: 58549087935     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K08E-077     Document Type: Article

References (41)

1. Reaven GM (1988) Banting lecture: Role of insulin resistance in human disease. Diabetes 37: 1595-1607.
2. Mulhall BP, Ong JP, Younossi ZM (2002) Non-alcoholic fatty liver disease: an overview. J Gastroenterol Hepatol 17: 1136-1143.
3. Angulo P, Lindor KD (2002) Non-alcoholic fatty liver disease. J Gastroenterol Hepatol 17 (Suppl.): S186-190.
4. Shoelson SE, Lee J, Goldfine AB (2006) Inflammation and insulin resistance. J Clin Invest 116: 1793-1801.
5. Costa A, Igualá I, Bedini J, Quintó L, Conget I (2002) Uric acid concentration in subjects at risk of type 2 diabetes mellitus: relationship to components of the metabolic syndrome. Metabolism 51: 372-375.
6. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N (2001) Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50: 1844-1850.
7. Hanley AJ, Williams K, Festa A, Wagenknecht LE, D'Agostino RB Jr, Haffner SM (2005) Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. Diabetes 54: 3140-3147.
8. Schmidt MI, Duncan BB, Sharrett AR, Lindberg G, Savage PJ, Offenbacher S, Azambuja MI, Tracy RP, Heiss G (1999) Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 353: 1649-1652.
9. Friedman GD, Tekawa I, Grimm RH, Manolio T, Shannon SG, Sidney S (1990) The leucocyte count: correlates and relationship to coronary risk factors - the CARDIA study. Int J Epidemiol 19: 889-893.
10. Madjid M, Awan I, Willerson JT, Casscells SW (2004) Leukocyte count and coronary heart disease: implications for risk assessment. J Am Coll Cardiol 44: 1945-1956.
11. Vozarova B, Weyer C, Lindsay RS, Pratley RE, Bogardus C, Tataranni PA (2002) High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51: 455-461.
12. Onat A, Uyarel H, Hergenç G, Karabulut A, Albayrak S, Sari I, Yazici M, Keleş I (2006) Serum uric acid is a determinant of metabolic syndrome in a population-based study. Am J Hypertens 19: 1055-1062.
13. Carol AM (1992) General Ultrasound. Edinburgh: Churchill Livingstone; 184-186.
14. Alberti KG, Zimmet P. Shaw J (2006) Metabolic syndrome: a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 223: 469-480.
15. 2001 Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486-2497.
16. Steering Committee of the WHO Western Pacific Region, IASO & IOTF (2000) The Asia-Pacific perspective: Redefining obesity and its treatment.
17. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F; American Heart Association; National Heart, Lung, and Blood Institute (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735-2752.
18. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, McCullough AJ, Natale S, Forlani G, Melchionda N (2001) Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50: 1844-1850.
19. Vozarova B, Stefan N, Lindsay RS, Saremi A, Pratley RE, Bogardus C, Tataranni PA (2002) High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes 51: 1889-1895.
20. Sattar N, Scherbakova O, Ford I, O'Reilly DS, Stanley A, Forrest E, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J; west of Scotland coronary prevention study (2004) Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the West of Scotland Coronary Prevention Study. Diabetes 53: 2855-2860.
21. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH (2004) Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40: 1387-1395.
22. Seppälä-Lindroos A, Vehkavaara S, Häkkinen AM, Goto T, Westerbacka J, Sovijärvi A, Halavaara J, Yki-Järvinen H (2002) Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 87: 3023-3028.
23. Bugianesi E, Gastaldelli A, Vanni E, Gambino R, Cassader M, Baldi S, Ponti V, Pagano G, Ferrannini E, Rizzetto M (2005) Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia 48: 634-642.
24. Targher G, Seidell JC, Tonoli M, Muggeo M, De Sandre G, Cigolini M (1996) The white blood cell count: its relationship to plasma insulin and other cardiovascular risk factors in healthy male individuals. J Intern Med 239: 435-441.
25. Nakanishi N, Yoshida H, Okamoto M, Matsuo Y, Suzuki K, Tatara K (2003) Association of alcohol consumption with white blood cell count: a study of Japanese male office workers. J Intern Med 253: 367-374.
26. Rader DJ (2000) Inflammatory markers of coronary risk. N Engl J Med 343: 1179-1182.
27. Desai MY, Dalal D, Santos RD, Carvalho JA, Nasir K, Blumenthal RS (2006) Association of body mass index, metabolic syndrome, and leukocyte count. Am J Cardiol 97: 835-838.
28. Lohsoonthorn V, Dhanamun B, Williams MA (2006) Prevalence of metabolic syndrome and its relationship to white blood cell count in a population of Thai men and women receiving routine health examinations. Am J Hypertens 19: 339-345.
29. Schmidt MI, Duncan BB, Watson RL, Sharrett AR, Brancati FL, Heiss G (1996) A metabolic syndrome in whites and African-Americans. The Atherosclerosis Risk in Communities baseline study. Diabetes Care 19: 414-418.
30. Yoo TW, Sung KC, Shin HS, Kim BJ, Kim BS, Kang JH, Lee MH, Park JR, Kim H, Rhee EJ, Lee WY, Kim SW, Ryu SH, Keum DG (2005) Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J 69: 928-933.
31. Tsouli SG, Liberopoulos EN, Mikhailidis DP, Athyros VG, Elisaf MS (2006) Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander? Metabolism 55: 1293-1301.
32. Lin JD, Chiou WK, Chang HY, Liu FH, Weng HF (2007) Serum uric acid and leptin levels in metabolic syndrome: a quandary over the role of uric acid. Metabolism 56: 751-756.
33. Quiñones Galvan A, Natali A, Baldi S, Frascerra S, Sanna G, Ciociaro D, Ferrannini E (1995) Effect of insulin on uric acid excretion in humans. Am J Physiol 268: E1-E5.
34. Hikita M, Ohno I, Mori Y, Ichida K, Yokose T, Hosoya T (2007) Relationship between hyperuricemia and body fat distribution. Intern Med 46: 1353-1358.
35. Modan M, Halkin H, Karasik A, Lusky A (1987) Elevated serum uric acid - a facet of hyperinsulinaemia. Diabetologia 30: 713-718.
36. Fox IH (1981) Metabolic basis for disorders of purine nucleotide degradation. Metabolism 30: 616-634.
37. Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, Ouyang X, Feig DI, Block ER, Herrera-Acosta J, Patel JM, Johnson RJ (2006) A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 290: 625-631.
38. Nieto FJ, Iribarren C, Gross MD, Comstock GW, Cutler RG (2000) Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis 148: 131-139.
39. Nyyssonen K, Porkkala-Sarataho E, Kaikkonen J (1997) Ascorbate and urate are the strongest determinants of plasma antioxidative capacity and serum lipid resistance to oxidation in Finish men. Atherosclerosis 130: 223-233.
40. Evans JL, Maddux BA, Goldfine ID (2005) The molecular basis for oxidative stress-induced insulin resistances. Antioxid Redox Signal 7: 1040-1052.
41. Lonardo A, Loria P, Leonardi F, Borsatti A, Neri P, Pulvirenti M, Verrone AM, Bagni A, Bertolotti M, Ganazzi D, Carulli N; POLI.ST.E.N.A. Study Group. Policentrica Steatosi Epatica Non Alcolica (2002) Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study. Dig Liver Dis 34: 204-211.